Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P49
Within normal range
vs 2Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.44% |
| Q3 2025 | -17.79% |
| Q2 2025 | 35.91% |
| Q1 2025 | 18.88% |
| Q4 2024 | -890.43% |
| Q3 2024 | 137.81% |
| Q2 2024 | -164.28% |
| Q1 2024 | 253.73% |
| Q4 2023 | 10.90% |
| Q3 2023 | -25.25% |
| Q2 2023 | 16.98% |
| Q1 2023 | -236.32% |
| Q4 2022 | -63.98% |
| Q3 2022 | 39.02% |
| Q2 2022 | -103.31% |
| Q1 2022 | -8.30% |
| Q4 2021 | 37.00% |
| Q3 2021 | -86.40% |
| Q2 2021 | -80.03% |
| Q1 2021 | 18.29% |
| Q4 2020 | -124.85% |
| Q3 2020 | 60.14% |
| Q2 2020 | 1.62% |
| Q1 2020 | 32.55% |
| Q4 2019 | -95.71% |
| Q3 2019 | 33.71% |
| Q2 2019 | 26.38% |
| Q1 2019 | -20.11% |
| Q4 2018 | 30.89% |
| Q3 2018 | -11.33% |
| Q2 2018 | -34.07% |
| Q1 2018 | 29.09% |
| Q4 2017 | 8.31% |
| Q3 2017 | -36.93% |
| Q2 2017 | 18.32% |
| Q1 2017 | 10.60% |
| Q4 2016 | -22.76% |
| Q3 2016 | -11.98% |
| Q2 2016 | -59.86% |
| Q1 2016 | 6.73% |